Ever expanding rapid diagnostic products

Inverness Medical Innovations develops and manufactures rapid diagnostic products for use in preventive as well as interventional therapies.

Photo: Ever expanding rapid diagnostic products

Information from patients’ body fluids, or tissue, assists physicians to diagnose disease, as well as to measure a patient’s response to a specific therapy. Its range of clinical diagnostic products already includes, the well-known brands Clearview, Inverness Medical TestPack, Binax, Determine, BioStar, and many others. ‘Our high quality immunoassays in pregnancy testing and fertility, respiratory, enteric and infectious diseases, autoimmune disorders, osteoporosis, cancer and cardiology, have demonstrated proven efficiency in clinics, hospitals and laboratories internationally,’ the firm points out.

Currently, Inverness Medical Innovations reports that it is exploring opportunities to optimise the use of its technologies, as well as continually evaluating other technological advances, for development or acquisition, in a variety of medical/health areas.

14.11.2006

More on the subject:

Related articles

Photo

News • Restoring antibacterial efficacy

New hydrogel helps overcome antibiotic resistance

In the laboratory, researchers increased the bactericidal effect of antibiotics 64-fold with the use of a new hydrogel. The material made the antibiotics effective even against resistant bacteria.

Photo

News • Incidentaloma detection

Liquid biopsy as diagnostic tool for pancreatic lesions

New research highlights the potential of liquid biopsy in diagnosing pancreatic incidentaloma - lesions which can occasionally signal pancreatic cancer in its earliest stages.

Photo

News • Blood vessel-like coating

New material to protect devices against blood clot formation

Protection against blood clots: A new material, designed to mimic blood vessels, could allow for safer use of devices like catheters, stents, blood-oxygenation machines and dialysis machines.

Related products

Subscribe to Newsletter